Fast answer

BPC-157 is a synthetic pentadecapeptide used in preclinical healing and repair research. Learn its profile, how it compares to TB-500, and how to verify HPLC/ESI-MS lots.

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide — a 15-amino-acid sequence derived from a protein found in human gastric juice. It is one of the most frequently requested tool compounds in preclinical healing and repair research. This overview covers what BPC-157 is, the kinds of studies it appears in, how it differs from TB-500, and how to source a properly documented lot.

Research status. BPC-157 is not an approved drug, and the published evidence is predominantly preclinical (cell and animal models). Peplxa supplies lyophilized BPC-157 acetate for qualified in-vitro laboratory research only, with no human-use or dosing guidance.

What is BPC-157?

BPC-157 is a fragment of human gastric juice protein, synthesized as a stable acetate salt for laboratory use. In research literature it is associated with work on tissue protection and repair signaling, and it has become a common reference compound in programs studying connective-tissue and gastrointestinal healing models. Because much of the public discussion around it is anecdotal, laboratories should rely on peer-reviewed preclinical literature rather than marketing claims when designing studies.

Research themes around BPC-157

These are research themes, not established clinical effects. Reproducible work depends on correctly identified, high-purity reference material.

BPC-157 vs TB-500

AttributeBPC-157TB-500
Identity15-aa fragment of a gastric juice proteinSynthetic fragment of thymosin beta-4
Mechanism studiedTissue-protection / repair signalingActin-sequestering protein; cell-migration and tissue-repair models
Common formatLyophilized acetate vialLyophilized acetate vial
Peplxa listingBPC-157 (Acetate)TB-500 (Thymosin B4 Acetate)

Researchers who run both as separate arms can also use the BPC-157 + TB-500 blend, while a shorter thymosin beta-4 sequence is available as TB4-FRAG. All belong to the healing and repair research category.

Verifying a BPC-157 lot

Peptide identity is confirmed by mass, not by the label. For every lot, require:

Peplxa runs reverse-phase HPLC (UV 214 nm) and ESI-MS positive-mode identity before release; the workflow is described on the testing method page and records render on the Lot Records page by compound.

Storage and handling (laboratory notes)

Keep sealed lyophilized vials frozen near -20°C and protected from light. If a protocol requires reconstitution, use sterile diluent, run it down the inner vial wall and roll gently; do not shake. Refrigerate reconstituted material at 2-8°C and use promptly. Peplxa does not specify concentrations or dosing, which are protocol-level decisions.

Sourcing

Use the verification steps in the buying research peptides guide, inspect the lot record before ordering, and prefer a supplier with research-only terms and tracked, discreet dispatch. The BPC-157 product page lists current box specifications, and laboratories buying across a repair program can request tiered pricing through the wholesale guide.

For in-vitro laboratory research use only. This material is not a drug, food, cosmetic or supplement and has not been evaluated by any regulatory authority. Peplxa does not provide usage, dosing or medical guidance; all handling must follow applicable laboratory safety regulations.

Frequently Asked Questions

What is BPC-157?
BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide derived from a sequence found in a human gastric juice protein. It is used as a tool compound in preclinical in-vitro and animal-model healing and repair research. It is not an approved drug and is sold for laboratory research only.
What is BPC-157 studied for?
Published preclinical studies have examined BPC-157 in models of tendon and ligament injury, gastrointestinal healing, angiogenesis and mucosal protection. These findings come from cell and animal models and have not been established as effects in humans; no clinical or dosing guidance is provided.
What is the difference between BPC-157 and TB-500?
TB-500 is a synthetic fragment of thymosin beta-4, an actin-binding protein, and is studied in tissue-repair and cell-migration models. BPC-157 is a gastric-protein-derived pentadecapeptide. They are distinct molecules and are sometimes run as separate arms in the same preclinical program; Peplxa also lists a BPC-157 + TB-500 blend for researchers who want both in one box.
What form is BPC-157 supplied in?
As a sealed, lyophilized acetate salt in glass vials, supplied in boxes of ten across specification tiers. The exact current specifications are on the BPC-157 product page.
How do I verify a BPC-157 lot?
Match the vial lot to an independent HPLC purity trace and an ESI-MS identity report, confirming the observed mass matches the theoretical mass of BPC-157 acetate. Peplxa renders these records by compound on the Lot Records page with no login.
Do you provide dosing or injection instructions?
No. Peplxa is a research-only supplier and does not provide human dosing, administration or medical advice. Only general laboratory storage and handling notes are provided.